Adnan Bekdur has joined the firm as a partner in its corporate & securities practice, establishing a dedicated corporate ...

Two Dechert partners have been selected as MVPs of the Year for 2026 by leading legal publication Law360. Each year, the publication names just a handful of lawyers per practice area across a range of ...

The Dechert Antitrust Merger Investigation Timing Tracker (DAMITT) is a quarterly study reporting on trends in significant ...

On October 22, 2026, the U.S. Department of the Treasury ("Treasury") issued a proposed rule (the "Proposed Rule") to ...

This is the second in our series of follow-up pieces to CFO Market Update 2026, each taking a closer look at a topic we ...

A federal court in California denied class certification in a vehicle defect suit because evidence of the manufacturer’s ...

The SEC’s Division of Examinations (“EXAMS”) issued its 2027 examination priorities, which reinforce fiduciary obligations ...

Explore new DOJ and HHS healthcare self-disclosure policies, including False Claims Act eligibility, repayment terms and key deadlines for healthcare companies.

At Dechert, we forecast a great many things. Election results are not one of them, and we take no position on which party should prevail. What we can forecast is what follows from either plausible ...

Paul Stevens is a partner in Dechert’s financial services practice. Mr. Stevens is known for his work on regulated funds that provide retail investors access to private markets. Although he routinely ...

David Manjorin is an associate in Dechert’s corporate and securities practice with a focus on capital markets transactions. Mr. Manjorin advises issuers in connection with public and private offerings ...